Tango Therapeutics Valuation
| TNGX Stock | USD 7.51 0.16 2.09% |
At this time, the company appears to be undervalued. Tango Therapeutics has a current Real Value of $9.93 per share. The regular price of the company is $7.51. Our model measures the value of Tango Therapeutics from inspecting the company fundamentals such as Return On Equity of -0.45, operating margin of (6.53) %, and Shares Outstanding of 106.85 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend acquiring undervalued stocks and dropping overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Tango Therapeutics' valuation include:
Price Book 3.1032 | Enterprise Value 514.1 M | Enterprise Value Ebitda (4.36) | Price Sales 21.5031 | Enterprise Value Revenue 13.3458 |
Undervalued
Today
Please note that Tango Therapeutics' price fluctuation is somewhat reliable at this time. Calculation of the real value of Tango Therapeutics is based on 3 months time horizon. Increasing Tango Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Tango Therapeutics is useful when determining the fair value of the Tango stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Tango Therapeutics. Since Tango Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tango Stock. However, Tango Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.51 | Real 9.93 | Target 17.6 | Hype 7.48 |
The real value of Tango Stock, also known as its intrinsic value, is the underlying worth of Tango Therapeutics Company, which is reflected in its stock price. It is based on Tango Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Tango Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tango Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tango Therapeutics helps investors to forecast how Tango stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tango Therapeutics more accurately as focusing exclusively on Tango Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tango Therapeutics' intrinsic value based on its ongoing forecasts of Tango Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tango Therapeutics' closest peers. When choosing an evaluation method for Tango Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Tango Therapeutics Investments |
|
Tango Valuation Trend
Knowing Tango Therapeutics' actual value is paramount for traders to make sound investment determinations. Tango Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Tango Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Tango Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Tango Market Cap
Tango Therapeutics is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 22.13 Billion. Tango Therapeutics holds roughly 819.51 Million in market capitalization claiming about 4% of equities under Health Care industry.Tango Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Tango Therapeutics's current stock value. Our valuation model uses many indicators to compare Tango Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tango Therapeutics competition to find correlations between indicators driving Tango Therapeutics's intrinsic value. More Info.Tango Therapeutics is rated below average in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 6.93 of Price To Sales per Price To Book. At this time, Tango Therapeutics' Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Tango Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tango Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tango Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Tango Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Tango Therapeutics and how it compares across the competition.
About Tango Therapeutics Valuation
The stock valuation mechanism determines the current worth of Tango Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Tango Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tango Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Tango Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tango Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tango Therapeutics. We calculate exposure to Tango Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tango Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 34.1 M | 21 M | |
| Pretax Profit Margin | (2.78) | (2.92) | |
| Operating Profit Margin | (3.13) | (3.28) | |
| Net Loss | (2.79) | (2.92) | |
| Gross Profit Margin | 0.93 | 0.52 |
8 Steps to conduct Tango Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tango Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tango Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tango Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tango Therapeutics' revenue streams: Identify Tango Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tango Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tango Therapeutics' growth potential: Evaluate Tango Therapeutics' management, business model, and growth potential.
- Determine Tango Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tango Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tango Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Tango Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 94.6 M |
Tango Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Tango Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tango we look at many different elements of the entity such as Tango's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Tango Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tango Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tango Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tango Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tango Therapeutics' worth.When determining whether Tango Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tango Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tango Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tango Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tango Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.Note that the Tango Therapeutics information on this page should be used as a complementary analysis to other Tango Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Tango Stock analysis
When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Tango Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tango Therapeutics. If investors know Tango will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tango Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Revenue Per Share 0.374 | Quarterly Revenue Growth 0.122 | Return On Assets (0.19) | Return On Equity (0.45) |
The market value of Tango Therapeutics is measured differently than its book value, which is the value of Tango that is recorded on the company's balance sheet. Investors also form their own opinion of Tango Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tango Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tango Therapeutics' market value can be influenced by many factors that don't directly affect Tango Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tango Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tango Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tango Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.